Skip to content

Comparing a Group-based Guided Self-help Approach to Pure Self-help for the Treatment of BED

A Randomized Controlled Trial Comparing a Group-based Guided Self-help Approach to Pure Self-help for the Treatment of Binge Eating Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04432311
Enrollment
164
Registered
2020-06-16
Start date
2021-01-05
Completion date
2023-07-20
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Eating Disorder

Keywords

Binge Eating Disorder, Binge Focused Therapy (BFT), Self-Help, Guided Self-Help

Brief summary

Binge eating disorder (BED) is the most common eating disorder in adults, affecting 2.8% of the population. The disorder is characterized by recurrent episodes of binge eating which are not followed by inappropriate compensatory behaviours such as self-induced vomiting. BED is associated with an increased risk of health complications, significant impairment to social and occupational functioning, and reduced quality of life. Despite the negative consequences associated with this disorder, standard therapy for BED is often inaccessible and costly. To address the limitations of standard therapy for BED our research team has developed Binge Focused Therapy (BFT) as an innovative, guided self-help approach to BED treatment. BFT was derived from elements of The Brain Over Binge Recovery Guide by Kathryn Hansen, which incorporates fundamental aspects of Acceptance and Commitment Therapy, Dialectical Behaviour Therapy, Motivational Enhancement Therapy, and addictions treatment. We further streamlined this approach into a protocol that can be delivered by non eating disorder specialists (e.g., honours psychology students, nurses, occupational therapists). In 2018, our research team conducted a proof-of-concept pilot study with a sample of 40 individuals with BED. Unpublished results of this uncontrolled study indicated that the sample experienced significant reductions in binge episodes per month, binge eating severity, general eating disorder symptomology, and improved confidence in changing binge eating behaviours. Although the results from this small, uncontrolled, proof-of-concept study are encouraging, qualitative and quantitative data highlighted several aspects of the BFT intervention that could be altered and tested in a randomized controlled trial that compares BFT to an active comparator.

Interventions

BEHAVIORALBinge Focused Therapy (BFT)

The BFT group will be provided Binge Focused Therapy, a group-based, guided-self help intervention. Participants in this group will attend three online group sessions spread over six weeks (Week 1, Week 2, and Week 6) and complete homework between sessions. Following Session 3, there is a four week period where participants complete self-guided check-ins once per week to monitor continued progress and/or signs of relapse.

BEHAVIORALCBT Unguided Self Help (CBT USH)

The CBT USH group will be provided with the book, Overcoming Binge Eating by C. Fairburn, which is a well-established self-help book used to help individuals understand binge eating and control binge eating behaviours. After participants receive the book, they will have 10 weeks to read it and work through the exercises provided in the book.

Sponsors

Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Meets criteria for Diagnostic and Statistical Manual of Mental Disorders (5th Edition) diagnosis of BED (mild-extreme) as per Eating Disorder Examination - Mild severity will be modified from a minimum of 1 objective binge episode/week to 2 objective binge episodes per week * Age 18 or older * Access to computer with internet connection and webcam that can be used in a private area * Virtually signed informed consent form

Exclusion criteria

* Currently receiving psychotherapy/treatment for BED (as determined by PI) * Self-reported Body Mass Index on pre-screening questionnaire \< 20 kg/m2 * Dose change of a psychotropic medication used for the treatment of BED (e.g., Vyvanse, topiramate, antidepressants) or any medication that could have an effect on appetite/binging (e.g., Saxenda) within 4 weeks of study inclusion (as determined by PI) * Insufficient knowledge of English * Previously participated in proof-of-concept BFT study * Previously read Overcoming Binge Eating by C. Fairburn and implemented strategies presented in the book (as determined by PI) * Serious physical illness (e.g., severe uncontrolled insulin dependent diabetes) (as determined by PI) * Currently pregnant * Scores greater than 20 on the Quick Inventory of Depressive Symptomatology Self-Report and PI determines participant is significantly depressed (as determined by PI) * Currently experiencing serious issues with alcohol or drugs (as determined by PI) * Currently engaging in self-harm behaviours (as determined by PI)

Design outcomes

Primary

MeasureTime frameDescription
Binge Eating SymptomologyBaseline to Post-Treatment (10 week)This will be measured using the global score generated from the Binge Eating Scale (BES). The BES is a 16-item measure, each item has 3-4 coded responses. The total score ranges from 0-46, where a higher score indicates greater binge eating severity.

Secondary

MeasureTime frameDescription
Binge Eating FrequencyBaseline, 6 week, 10 week, 6-month follow-up, 12-month follow-upSelf reported changes in Binge Eating Frequency over past 28 days will be measured using Item 15 from the Eating Disorder Examination Questionnaire 6.0 (EDE-Q; Fairburn & Beglin, 1994) which inquires about the number of days with objective binge episodes over the past 28 days.
Eating Disorder Symptomology (Eating Disorder Examination Questionnaire)Baseline, 6 week, 10 week, 6-month follow-up, 12-month follow-upSelf reported changes in Eating Disorder Symptomology will be measured using the global score generated from the EDE-Q (Fairburn & Beglin, 1994). The EDE-Q is a 28-item measure that assesses four areas of eating disorder psychopathology (eating concern, shape concern, weight concern, dietary restraint). Each item uses a Likert scale ranging from 0 (lowest frequency/severity) to 6 (highest frequency/severity). The global score ranges from 0-6 where higher scores indicate greater impairment. The global score is obtained using the mean of the four subscales.
Clinical ImpairmentBaseline, 6 week, 10 week, 6-month follow-up, 12-month follow-upSelf reported changes in clinical impairment will be measured using the Clinical Impairment Assessment Questionnaire (CIA; Bohn & Fairburn, 2008). This is a 16-item self-report measure of the severity of psychosocial impairment due to eating disorder features over the past 28 days. Each item is ranked on a 0-3 scale (0 being not at all and 3 being a lot). Total scores range from 0-48, with higher scores indicating greater clinical impairment.
Confidence to Change Binge EatingBaseline, 6 week, 10 week, 6-month follow-up, 12-month follow-upConfidence to Change Binge Eating will be measured using the question, On a scale from 1 to 10, how confident are you that you can change your binge eating if you wanted to?, with higher scores indicating greater confidence. This question assesses perceived confidence in ability to change binge eating.
Binge Eating Symptomology6 week, 6-month follow-up, 12-month follow-upThis will be measured using the global score generated from the Binge Eating Scale (BES). The BES is a 16-item measure, each item has 3-4 coded responses. The total score ranges from 0-46, where a higher score indicates greater binge eating severity.
RemissionWeek 10, 6-month follow-up, 12-month follow-upRemission is defined as meeting criteria for abstinence (100% reduction in binge episodes in the 28 days prior to collecting outcome measures) in addition to having EDEQ global score less than or equal to 2.77 (Fairburn & Beglin, 1994).
Intervention AdherenceWeek 6, Week 10Intervention adherence for participants in the BFT group will be based on session attendance. Completers will be defined as anyone who completes Session 1 and at least one other session. Adherence questionnaires at Week 6 and Week 10 time points inquire about which aspects of the intervention outside of the sessions have been used. Intervention adherence for participants in the CBT USH group will be calculated using questionnaires provided at both the Week 6 and Week 10 time points that inquire about which chapters have been read and which CBT Steps have been completed thus far. Completers will be defined as anyone who indicates that they have read Chapters 1, 4, 5, and 'Getting Ready', and completed Step 1 through Step 3.
Participant ExpectationsPre-Intervention, Week 1This will be measured using the Credibility and Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000). The CEQ is a six item self-report measure that measures treatment expectancy and rationale credibility of therapeutic interventions. Each item is scored on a 1-9 Likert-type scale or as a percentage rating from 0% to 100% in increments of 10%. Higher scores indicate greater credibility/expectancy of the intervention.
Satisfaction with InterventionWeek 10Participants in both groups will respond to developed Likert-style and open-ended questions asking about their perceptions of their assigned program. Each Likert item is ranked on a scale from 1-9. Higher total scores indicate greater satisfaction with the intervention.
AbstinenceWeek 10, 6-month follow-up, 12-month follow-upAbstinence is defined as a 100% reduction in binge episodes in the 28 days prior to collecting outcome measures.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026